{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:53:22Z","timestamp":1762113202296},"reference-count":46,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T00:00:00Z","timestamp":1265328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold> Recent clinical guidelines advocate the use of the isosorbide dinitrate\/hydralazine combination in treatment for heart failure. However, clinical and laboratory evidence suggest that some vasodilators may induce cardiac hypertrophy under uncertain conditions. This study investigated the effects and underlying mechanism of action of the vasodilator hydralazine on cardiac growth.<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold> Wild\u2010type mice and animals deficient in guanylyl cyclase\u2010A (GCA) and\/or angiotensin receptors (AT<jats:sub>1<\/jats:sub> and AT<jats:sub>2<\/jats:sub> subtypes) were treated with hydralazine (\u224824\u2003mg\u00b7kg<jats:sup>\u22121<\/jats:sup>\u00b7day<jats:sup>\u22121<\/jats:sup> in drinking water) for 5 weeks. Cardiac mass and\/or cardiomyocyte cross\u2010sectional area, fibrosis (van Giessen\u2010staining) and cardiac gene expression (real\u2010time RT\u2010PCR) were measured.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold> Hydralazine lowered blood pressure in mice of all genotypes. However, this treatment increased the heart and left ventricular to body weight ratios, as well as cardiomyocyte cross\u2010sectional area, and cardiac expression of atrial natriuretic peptide mRNA in mice lacking GCA. Hydralazine did not affect cardiac hypertrophy in wild\u2010type mice and mice lacking either AT<jats:sub>1<\/jats:sub> or AT<jats:sub>2<\/jats:sub> receptors alone. However, the pro\u2010hypertrophic effect of hydralazine was prevented in mice lacking both GCA and AT<jats:sub>2<\/jats:sub>, but not GCA and AT<jats:sub>1<\/jats:sub> receptors. However, hydralazine did decrease cardiac collagen deposition and collagen I mRNA (signs of cardiac fibrosis) in mice that were deficient in GCA, or both GCA and AT<jats:sub>2<\/jats:sub> receptors.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold> The vasodilator hydralazine induced AT<jats:sub>2<\/jats:sub> receptor\u2010mediated cardiomyocyte growth under conditions of GCA deficiency. However, attenuation of cardiac fibrosis by hydralazine could be beneficial in the management of cardiac diseases.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2009.00619.x","type":"journal-article","created":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T14:08:22Z","timestamp":1265378902000},"page":"1133-1142","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vasodilator therapy with hydralazine induces angiotensin AT<sub>2<\/sub> receptor\u2010mediated cardiomyocyte growth in mice lacking guanylyl cyclase\u2010A"],"prefix":"10.1111","volume":"159","author":[{"given":"Y","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.1.35"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2795(72)90140-7"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000193504.51489.cf"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1139\/y85-029"},{"key":"e_1_2_8_6_1","first-page":"784","volume-title":"The Pharmacological Basis of Therapeutics","author":"Gerber JG","year":"1990"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00368-1"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2005.12.001"},{"key":"e_1_2_8_9_1","first-page":"e154","article-title":"American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult","volume":"112","author":"Hunt SA","year":"2005","journal-title":"Circulation"},{"key":"e_1_2_8_10_1","first-page":"e391","article-title":"2009 focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation","volume":"119","author":"Hunt SA","year":"2009","journal-title":"Circulation"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.11.013"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2004.09.003"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.104.3.346"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90684-3"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000134924.89412.70"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198702000-00011"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90160-4"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000029923.57048.61"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0816"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-1353"},{"key":"e_1_2_8_21_1","first-page":"H844","article-title":"Distribution and function of cardiac angiotensin AT1\u2010 and AT2\u2010receptor subtypes in hypertrophied rat hearts","volume":"267","author":"Lopez JJ","year":"1994","journal-title":"AM J Physiol"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/378065a0"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.36.5.845"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1993.1021"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(85)90557-0"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000173420.31354.ef"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.86.8.841"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.6.1991"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.26.14730"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/16.1.40"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.12.081"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000062881.36813.7A"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.35.5.775"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/11.5.427"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10037"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.73.3.439"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1999.79.1.215"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042934"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1139\/y86-257"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.11.4.376"},{"issue":"3","key":"e_1_2_8_41_1","first-page":"H876","article-title":"Arterial vasodilators, cardiac volume load, and cardiac hypertrophy in normotensive rats","volume":"256","author":"Tsoporis J","year":"1989","journal-title":"Am J Physiol"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/hy1001.092649"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90005-8"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.87.1.70"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.83.10.1035"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.31.89"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00361.2003"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2009.00619.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2009.00619.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:14:33Z","timestamp":1694650473000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2009.00619.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1476-5381.2009.00619.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00619.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"2010-03-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}